Name | PD0332991 HCl | CAS# | 827022-32-2 | |
---|---|---|---|---|
Price | ¥Inquiry/1g | Purity | 98.9% | |
Stocking Period |
1 Day | Stock | In Stock |
Detail
Product Information
Palbociclib is an oral, small molecule cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, now in Phase 3 clinical development for advanced breast cancer. |
Get all suppliers by the below link:
2024-07-15 |
PD0332991HCl
Price: Inquiry |
2020-01-06 |
Palbociclib (PD0332991 HCl)
Price: $200.0 |
2022-05-12 |
Palbociclib HCl
Price: $Inquiry |
2023-08-31 |
Palbociclib hcl
Price: ¥Inquiry |
2018-02-06 |
PD0332991.HCl
Price: ¥Inquiry |
2017-11-13 |
PD0332991 HCl
Price: ¥Inquiry |
2021-05-10 |
PD0332991 HCl
Price: ¥Inquiry |
2017-12-16 |
PD 0332991 HCl
Price: ¥Inquiry |
2025-03-19 |
PD0332991 HCl
Price: ¥500.0 |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved